GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » PB Ratio

Hansoh Pharmaceutical Group Co (HKSE:03692) PB Ratio : 3.66 (As of Apr. 30, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-30), Hansoh Pharmaceutical Group Co's share price is HK$17.40. Hansoh Pharmaceutical Group Co's Book Value per Share for the quarter that ended in Dec. 2023 was HK$4.76. Hence, Hansoh Pharmaceutical Group Co's PB Ratio of today is 3.66.

The historical rank and industry rank for Hansoh Pharmaceutical Group Co's PB Ratio or its related term are showing as below:

HKSE:03692' s PB Ratio Range Over the Past 10 Years
Min: 2.25   Med: 5.12   Max: 56.52
Current: 3.66

During the past 8 years, Hansoh Pharmaceutical Group Co's highest PB Ratio was 56.52. The lowest was 2.25. And the median was 5.12.

HKSE:03692's PB Ratio is ranked worse than
75.49% of 963 companies
in the Drug Manufacturers industry
Industry Median: 1.96 vs HKSE:03692: 3.66

During the past 12 months, Hansoh Pharmaceutical Group Co's average Book Value Per Share Growth Rate was 6.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 19.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 50.60% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Hansoh Pharmaceutical Group Co was 103.60% per year. The lowest was 19.40% per year. And the median was 59.40% per year.

Back to Basics: PB Ratio


Hansoh Pharmaceutical Group Co PB Ratio Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co PB Ratio Chart

Hansoh Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial 10.33 10.41 4.59 3.47 3.31

Hansoh Pharmaceutical Group Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.59 3.79 3.47 2.82 3.31

Competitive Comparison of Hansoh Pharmaceutical Group Co's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansoh Pharmaceutical Group Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Hansoh Pharmaceutical Group Co's PB Ratio falls into.



Hansoh Pharmaceutical Group Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Hansoh Pharmaceutical Group Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=17.40/4.76
=3.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Hansoh Pharmaceutical Group Co  (HKSE:03692) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Hansoh Pharmaceutical Group Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Traded in Other Exchanges
Address
287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines